These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8302767)

  • 41. Baicalin pharmacokinetic profile of absorption process using novel in-vitro model: cytochrome P450 3A4-induced Caco-2 cell monolayers combined with rat intestinal rinse fluids.
    Morisaki T; Hou XL; Takahashi K; Takahashi K
    J Pharm Pharmacol; 2013 Oct; 65(10):1526-35. PubMed ID: 24028620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The intestinal uptake of "enzymatically-stable" peptide drugs in rats as influenced by D-glucose in situ.
    Hu Z; Tse EG; Monkhouse DC; Oh CK; Fleisher D
    Life Sci; 1994; 54(25):1977-85. PubMed ID: 8201846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery.
    Kamei N; Morishita M; Ehara J; Takayama K
    J Control Release; 2008 Oct; 131(2):94-9. PubMed ID: 18692532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physiological models are good tools to predict rat bioavailability of EF5154 prodrugs from in vitro intestinal parameters.
    Nomoto M; Tatebayashi T; Morita J; Suzuki H; Aizawa K; Kurosawa T; Komiya I
    J Pharm Sci; 2009 Apr; 98(4):1532-44. PubMed ID: 18683862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
    Dahan A; Amidon GL
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disposition, metabolism, and excretion of U-71038, a novel renin inhibitor peptide, in the rat.
    Greenfield JC; Cook KJ; O'Leary IA
    Drug Metab Dispos; 1989; 17(5):518-25. PubMed ID: 2573495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
    Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D
    Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
    Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
    Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved prediction of in vivo peroral absorption from in vitro intestinal permeability using an internal standard to control for intra- and inter-rat variability.
    Dowty ME; Dietsch CR
    Pharm Res; 1997 Dec; 14(12):1792-7. PubMed ID: 9453070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments.
    Artursson P; Ungell AL; Löfroth JE
    Pharm Res; 1993 Aug; 10(8):1123-9. PubMed ID: 8415396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The outstanding metabolic stability of a 14C-labeled beta-nonapeptide in rats--in vitro and in vivo pharmacokinetic studies.
    Wiegand H; Wirz B; Schweitzer A; Camenisch GP; Rodriguez Perez MI; Gross G; Woessner R; Voges R; Arvidsson PI; Frackenpohl J; Seebach D
    Biopharm Drug Dispos; 2002 Sep; 23(6):251-62. PubMed ID: 12214326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suitability of the in vitro Caco-2 assay to predict the oral absorption of aromatic amine hair dyes.
    Obringer C; Manwaring J; Goebel C; Hewitt NJ; Rothe H
    Toxicol In Vitro; 2016 Apr; 32():1-7. PubMed ID: 26578466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of transporters in oral absorption: a case study of in vitro and in vivo organic anion absorption.
    Gram LK; Rist GM; Steffansen B
    Mol Pharm; 2009; 6(5):1457-65. PubMed ID: 19548658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renin inhibitor: transport mechanism in rat small intestinal brush-border membrane vesicles.
    Hashimoto N; Fujioka T; Toyoda T; Muranushi N; Hirano K
    Pharm Res; 1994 Oct; 11(10):1448-51. PubMed ID: 7855050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intestinal metabolism and absorption of cholecystokinin analogs in rats.
    Su SF; Amidon GL; Lee HJ
    Biochem Biophys Res Commun; 2002 Apr; 292(3):632-8. PubMed ID: 11922613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a sensitive activity assay for high-volume evaluation of human renin inhibitory peptides in rat serum: results with U-71,038.
    Ruwart MJ; Sharma SK; Harris DW; Lakings DB; Rush BD; Wilkinson KF; Cornette JC; Evans DB; Friis JM; Cook KJ
    Pharm Res; 1990 Apr; 7(4):407-10. PubMed ID: 2194200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acylation of salmon calcitonin modulates in vitro intestinal peptide flux through membrane permeability enhancement.
    Trier S; Linderoth L; Bjerregaard S; Strauss HM; Rahbek UL; Andresen TL
    Eur J Pharm Biopharm; 2015 Oct; 96():329-37. PubMed ID: 26347924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies directed toward the design of orally active renin inhibitors. 1. Some factors influencing the absorption of small peptides.
    Rosenberg SH; Spina KP; Woods KW; Polakowski J; Martin DL; Yao Z; Stein HH; Cohen J; Barlow JL; Egan DA
    J Med Chem; 1993 Feb; 36(4):449-59. PubMed ID: 8474101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
    Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
    J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and in situ permeability of a 'second generation' hydroxypyridinone oral iron chelator: correlation with physico-chemical properties and oral activity.
    Lowther N; Fox R; Faller B; Nick H; Jin Y; Sergejew T; Hirschberg Y; Oberle R; Donnelly H
    Pharm Res; 1999 Mar; 16(3):434-40. PubMed ID: 10213376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.